Proxy Statement (Form DEF 14A)
SECURITIES AND EXCHANGE COMMISSION
__________________________________________
SCHEDULE 14A
(Rule 14a-101)
__________________________________________
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
|
Filed by the Registrant |
☒ |
|
|
Filed by a Party other than the Registrant |
☐ |
Check the appropriate box:
|
☐ |
Preliminary Proxy Statement |
|
|
☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
|
☒ |
Definitive Proxy Statement |
|
|
☐ |
Definitive Additional Materials |
|
|
☐ |
Soliciting Material Pursuant to §240.14a-12 |
(Exact name of registrant as specified in its charter)
_________________________________________________________________
(
Payment of Filing Fee (Check the appropriate box):
|
☒ |
No fee required. |
|
|
☐ |
Fee paid previously with preliminary materials. |
|
|
☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
Proxy Statement dated
and first mailed to stockholders on or about
Dear Stockholders:
You are cordially invited to attend a Special Meeting of Stockholders of
Your vote is very important! Whether or not you plan to attend the Special Meeting, we urge you to read the enclosed proxy statement and vote as soon as possible via the Internet, by telephone or, if you receive a paper proxy card or voting instruction form in the mail, by mailing the completed proxy card or voting instruction form.
Thank you for your confidence and continued support.
|
Sincerely, |
||
|
/s/ |
||
|
|
||
|
Chief Executive Officer |
Ness Ziona 7414003,
NOTICE OF SPECIAL MEETING OF STOCKHOLDERS
To be held
Notice is hereby given that a Special Meeting of Stockholders, or "Special Meeting," of
1. To approve the exercise of certain warrants into shares of common stock of the Company, par value
2. To approve the adjournment or postponement of the Special Meeting, if necessary, to continue to solicit votes for Proposal No. 1 ("Proposal No. 2"); and
3. To transact any other business that may properly come before the Special Meeting or any adjournment or postponement thereof.
Only
Your vote is important. Whether or not you are able to attend the virtual meeting, it is important that your shares be represented. To ensure that your vote is recorded promptly, please vote as soon as possible, even if you plan to attend the virtual meeting, by submitting your proxy via the Internet at the address listed on the proxy card or by signing, dating and returning the proxy card.
|
Important Notice Regarding the Availability of Proxy Materials for the Special Meeting to Be Held on |
|
By order of the Board of Directors, |
||
|
/s/ |
||
|
|
||
|
Chief Executive Officer |
TABLE OF CONTENTS
|
Page |
||
|
2 |
||
|
7 |
||
|
10 |
||
|
11 |
||
|
14 |
||
|
14 |
||
|
15 |
||
|
15 |
i
PROXY STATEMENT DATED
Ness Ziona 7414003,
PROXY STATEMENT
FOR THE SPECIAL MEETING OF STOCKHOLDERS
TO BE HELD
This proxy statement contains information about the Special Meeting of Stockholders (the "Special Meeting") of
All properly submitted proxies will be voted in accordance with the instructions contained in those proxies. If no instructions are specified, the proxies will be voted in accordance with the recommendation of our Board with respect to each of the matters set forth in the accompanying Notice of the Special Meeting of Stockholders. You may revoke your proxy at any time before it is exercised at the meeting by giving our corporate secretary written notice to that effect.
At the Special Meeting,
• approve the exercise of certain warrants (collectively, the "Warrants") into shares of common stock of the Company, par value
• approve the adjournment or postponement of the Special Meeting, if necessary, to continue to solicit votes for the above-mentioned proposal ("Proposal No. 2").
After careful consideration, the Board has approved the proposals referred to above, and has determined that they are advisable, fair and in the best interests of
Your vote is important. Whether or not you expect to attend the virtual Special Meeting, please complete, date, sign and promptly retuthe accompanying proxy card in the enclosed postage paid envelope to ensure that your shares will be represented and voted at the Special Meeting. You can also vote your shares via the internet or by telephone as provided in the instructions set forth in the enclosed proxy card. If you hold your shares in "street name" through a broker, you should follow the procedures provided by your broker.
We thank you for your consideration and continued support.
|
Yours sincerely, |
||
|
/s/ |
||
|
|
||
|
Chief Executive Officer |
This proxy statement is dated
1
PROXY STATEMENT
FOR THE SPECIAL MEETING OF STOCKHOLDERS
QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING
The following section provides answers to frequently asked questions about the Special Meeting. This section, however, only provides summary information. These questions and answers may not address all issues that may be important to you as a stockholder. You should carefully read this entire proxy statement, including Annex A.
When are this proxy statement and the accompanying materials scheduled to be sent to stockholders?
On or about
How do I attend the Special Meeting?
The meeting will be held entirely online on
Who is soliciting my vote?
Our Board is soliciting your vote for the Special Meeting.
When is the record date for the Special Meeting?
The record date for determination of stockholders entitled to vote at the Special Meeting (the "Record Date") is the close of business on
How many votes can be cast by all stockholders?
There were 24,966,053 shares of our Common Stock outstanding on
How do I vote?
By Internet at the Special Meeting.
Instructions on how to attend and vote at the Special Meeting are described at https://www.virtualshareholdermeeting.com/PHGE2025SM, although
By Proxy
If your shares are held directly in your own name, and you received printed copies of the proxy materials, you may vote your shares by mail by completing, signing and dating the proxy card. To vote over the internet or by telephone, you should refer to your proxy card for instructions.
If your shares are held in street name, meaning registered in the name of your broker, bank or other nominee, you should vote your shares by following the instructions from your broker, bank or other nominee.
2
To ensure your shares are voted by proxy, proxies submitted by Internet or by telephone should be received by the cutoff time of
If you complete and submit your proxy before the Special Meeting, the persons named as proxies will vote the shares represented by your proxy in accordance with your instructions. If you submit a proxy without giving voting instructions, your shares will be voted in the manner recommended by the Board on all matters presented in this proxy statement.
What shares are included on a proxy card or voting instruction form?
Each proxy card or voting instruction form represents the shares registered to you as of the close of business on the Record Date. You may receive more than one proxy card or voting instruction form if you hold your shares in multiple accounts, some of your shares are registered directly in your name with our transfer agent, or some of your shares are held in street name through a broker, bank, or other nominee. Please vote the shares on each proxy card or voting instruction form to ensure that all of your shares are counted at the Special Meeting.
What if I have shares registered in my name and don't vote on a particular matter when returning a proxy card?
Properly signed proxy cards received before the close of voting at the Special Meeting will be voted according to the directions provided. If a signed proxy card is returned without stockholder direction on a matter, the shares will be voted as recommended by the Board.
Can I change my vote?
Stockholder of Record: Shares Registered in Your Name
If your shares are registered directly in your name, you may change your vote or revoke your proxy by:
• delivering written notice to our Corporate Secretary or sent to our principal executive offices at
• submitting a later dated proxy over the internet or by telephone in accordance with the instructions in the proxy card; or
• voting your shares electronically during the Special Meeting.
If your shares are held in street name, you should contact your broker, bank or other nominee to change your vote or revoke your proxy.
How do I revoke my proxy?
You may revoke your proxy by (1) following the instructions on the proxy card and entering a new vote by mail that we receive before the start of the Special Meeting or over the Internet or by telephone by the cutoff time of
If a broker, bank, or other nominee holds your shares, you must contact such broker, bank, or nominee in order to find out how to change your vote.
3
How is a quorum reached?
Our amended and restated bylaws (as amended, the "Bylaws") provide that one-third (1/3) of the stock issued and outstanding and entitled to vote, present at the virtual meeting or represented by proxy, will constitute a quorum for the transaction of business at the Special Meeting.
Under the General Corporation Law of the
What proposals will be voted on at the Special Meeting?
There are two proposals scheduled to be voted on at the meeting:
1. Approval of the issuance of shares of Common Stock upon the exercise of the Warrants in accordance with Section 713 of the NYSE American Listed Company Guide ("Proposal No. 1," or the "Issuance Proposal").
2. Approval of, if necessary, the adjournment or postponement of the Special Meeting, to continue to solicit votes for Proposal No. 1 ("Proposal No. 2," or the "Adjournment Proposal").
What vote is required to approve each item at the Special Meeting?
You may vote "FOR," "AGAINST" or "ABSTAIN" on Proposal No. 1 and Proposal No. 2. Under our Bylaws, any proposal other than an election of directors is decided by the vote of the holders of a majority of the stock present in person or represented by proxy and entitled to vote on the question, unless the question is one upon which by express provision of law, our Certificate of Incorporation or our Bylaws, a different vote is required, in which case such express provision shall goveand control the decision of such question.
Proposal No. 1 requires the affirmative vote of the holders of a majority of the stock of the Company which is represented in person or by proxy at the Special Meeting and entitled to vote on the question.
Proposal No. 2 requires the affirmative vote of a majority of the stockholders present in person or represented by proxy at the meeting and entitled to vote, though less than a quorum (for the purpose of soliciting additional proxies to approve Proposal No. 1).
How is the vote counted?
If your shares are registered directly in your name, you are a "stockholder of record" who may vote at the meeting, and we are sending these proxy materials directly to you. As the stockholder of record, you have the right to direct the voting of your shares by voting over the Internet, by telephone, by returning your proxy or by voting online during the Special Meeting at https://www.virtualshareholdermeeting.com/PHGE2025SM.
If your shares are held in an account at a bank or at a brokerage firm or other nominee holder, you are considered the beneficial owner of shares held in "street name," and these proxy materials are being forwarded to you by your bank, broker or other nominee who is considered the stockholder of record for purposes of voting at the Special Meeting. As the beneficial owner, you have the right to direct your bank, broker or other nominee on how to vote your shares and to participate in the Special Meeting. You should receive a proxy card and voting instructions with these proxy materials from that organization rather than from us. You will receive instructions from your bank, broker or other nominee explaining how you can vote your shares and whether they permit Internet or telephone voting. Follow the instructions from your bank, broker or other nominee included with these proxy materials, or contact your bank, broker or other nominee to request a proxy form. We encourage you to provide voting instructions to your bank, broker or other nominee by giving your proxy to them. This ensures that your shares will be voted at the Special Meeting according to your instructions.
4
If you hold shares through a bank, broker or other intermediary firm, the intermediary firm is subject to certain
Abstentions, if any, would have the same effect as a vote "AGAINST" Proposals No. 1 and 2. Abstentions are counted as shares present and entitled to vote for the purpose of determining whether a quorum is present.
Are the proposals conditioned on one another?
None of the proposals are conditioned on another proposal.
Do I have appraisal rights?
Our stockholders are not entitled to dissenters' or appraisal rights under the General Corporation Law of the
Who pays the cost for soliciting proxies?
We will bear the cost of soliciting proxies, including the printing, mailing and filing of this proxy statement, the proxy card and any additional information furnished to stockholders. You will need to obtain your own internet access if you choose to access the proxy materials and/or vote over the internet.
Could other matters be decided at the Special Meeting?
We do not know of any other matters that may be presented for action at the Special Meeting. Should any other business come before the meeting, the persons named on the proxy will have discretionary authority to vote the shares represented by such proxies in accordance with their best judgment. If you hold shares through a broker, bank or other nominee as described above, they will not be able to vote your shares on any other business that comes before the Special Meeting unless they receive instructions from you with respect to such matter.
What happens if the meeting is postponed or adjourned?
Your proxy may be voted at the postponed or adjourned meeting. You will still be able to change your proxy until it is voted.
How can I know the voting results?
We plan to announce the final results in a Current Report on Form 8-K to be filed with the
Who can provide me with additional information and help answer my questions?
If you would like additional copies, without charge, of this proxy statement or if you have questions about the proposals being considered at the Special Meeting, including the procedures for voting your shares, you should contact
5
What is "householding" and how does it affect me?
With respect to eligible stockholders who share a single address, we may send only one copy of the proxy materials to that address unless we receive instructions to the contrary from any stockholder at that address. This practice, known as "householding," is designed to reduce our printing and postage costs. However, if a stockholder of record residing at such address wishes to receive separate proxy materials in the future, he or she may contact
We hereby undertake to deliver promptly, upon written or oral request, a copy of the proxy materials to a stockholder at a shared address to which a single copy of the document was delivered. Requests should be directed to the address set forth above.
6
PROPOSALS
PROPOSAL NO. 1:
ISSUANCE PROPOSAL
Overview
On
Pursuant to the terms of the Purchase Agreement and the Inducement Letter, the Company has agreed to submit to its stockholders for their consideration the approval of the exercise of the Warrants (as defined below) into shares of Common Stock in accordance with the rules of NYSE American. Section 713 of the NYSE American Listed Company Guide requires stockholder approval of transactions involving the issuance of 20% or more of a company's outstanding shares or voting power. The exercise of all of the Warrants would result in an issuance of 20% or more of
Background of the Proposal
Overview of Warrants
Pursuant to the terms of the Purchase Agreement, we issued (i) in a registered direct offering: (a) 2,828,283 shares of Common Stock and (ii) pre-funded warrants (the "Registered Pre-Funded Warrants") to purchase up to 805,231 shares of Common Stock (the "Registered Direct Offering") and (ii) in a concurrent private placement: (a) unregistered pre-funded warrants exercisable for an aggregate of 2,305,869 shares of Common Stock at an exercise price of
Shares Issuable upon Exercise of the Warrants
Set forth below is a table summarizing the exercise price and number of shares of Common Stock that are potentially issuable upon conversion of the Warrants. The sale into the public market of the underlying Common Stock could materially and adversely affect the market price of our Common Stock.
|
Exercise |
Common Stock |
||||
|
Private Placement Pre-Funded Warrants |
$ |
0.0001 |
2,305,869 |
||
|
Private Placement Common Warrants |
$ |
0.9306 |
5,939,383 |
||
|
New Common Warrants |
$ |
0.9306 |
6,955,528 |
||
|
Total |
N/A |
15,200,780 |
|||
Description of the Private Placement Pre-Funded Warrants
The Private Placement Pre-Funded Warrants may be exercised at any time following the approval of the Issuance Proposal at an exercise price of
7
The foregoing description of the Private Placement Pre-Funded Warrants does not purport to be complete and is qualified in its entirety by reference to the full text of the Private Placement Pre-Funded Warrant, the form of which is filed as Exhibit 4.2 to our Current Report on Form 8-K filed on
Description of the Private Placement Common Warrants
The Private Placement Common Warrants may be exercised at any time following stockholder approval of the Issuance Proposal at an exercise price of
The foregoing description of the Private Placement Common Warrants does not purport to be complete and is qualified in its entirety by reference to the full text of the Private Placement Common Warrant, the form of which is filed as Exhibit 4.3 to our Current Report on Form 8-K filed on
Description of the New Common Warrants
The terms of the New Common Warrants are substantially the same as those of the Private Placement Common Warrants.
The foregoing description of the New Common Warrants does not purport to be complete and is qualified in its entirety by reference to the full text of the New Common Warrant, the form of which is filed as Exhibit 4.4 to our Current Report on Form 8-K filed on
Reasons for the Proposal
Our Common Stock is listed on NYSE American, and, as such, we are subject to the applicable rules of the
Consequences of Not Approving the Proposal
If our stockholders do not approve this proposal, we will not be able to effect the exercise of the Warrants. Additionally, if our stockholders do not approve this proposal, we are required pursuant to the Purchase Agreement to use our reasonable best efforts to adjouthis Special Meeting one or more times to a date or dates no more than 90 days after the scheduled date for this Special Meeting, and to obtain such approval at such time. If the approval of this proposal is not then obtained, we are required pursuant to the Purchase Agreement to use our reasonable best efforts to obtain such approval as soon as practicable thereafter, and in any event to hold a special meeting of stockholders at least once every 90 days until we obtain approval of this proposal.
Consequences of Approving the Proposal
If our stockholders approve this proposal our existing stockholders will immediately experience significant dilution.
Interests of Certain Persons in the Proposal
When you consider our Board's recommendation to vote in favor of this proposal, you should be aware that certain of our directors, officers and existing stockholders may have interests that may be different from, or in addition to, the interests of other of our stockholders. In particular, the
8
and together with
Vote Required; Recommendation of Board
Stockholder approval of this Proposal No. 1 requires a "FOR" vote of the holders of a majority of the stock of the Company which is represented in person or by proxy at the Special Meeting and entitled to vote on the question (provided that a lawful quorum of stockholders be there represented in person or by proxy) (subject to the separate tabulation of votes described in "Questions and Answers About the Special Meeting - How many votes can be cast by all stockholders?"). Abstentions will have the effect of a vote "AGAINST" Proposal No. 1. Broker non-votes are not applicable for this Special Meeting because stockholders are being asked to vote on matters that are deemed "non-routine" and for which brokers do not have discretionary voting power.
THE BOARD RECOMMENDS THAT OUR STOCKHOLDERS VOTE "FOR" THE APPROVAL OF, UNDER APPLICABLE NYSE AMERICAN LISTING RULES, THE ISSUANCE OF SHARES OF COMMON STOCK UPON EXERCISE OF THE PRIVATE PLACEMENT WARRANTS AND INDUCEMENT WARRANTS.
9
PROPOSAL NO. 2:
APPROVAL OF ADJOURNMENT OF THE SPECIAL MEETING
General
If we fail to receive a sufficient number of votes to approve Proposal No. 1, we may propose to adjouor postpone the Special Meeting. We currently do not intend to propose adjournment or postponement at the Special Meeting if there are sufficient votes to approve Proposal No. 1.
Vote Required; Recommendation of Board
The affirmative vote of a majority of the stockholders present in person or represented by proxy at the meeting and entitled to vote, though less than a quorum, is required for approval of Proposal No. 2 (for the purpose of soliciting additional proxies to approve Proposal No. 1). Abstentions will have the effect of a vote "AGAINST" Proposal No. 2. Broker non-votes are not applicable for this Special Meeting because stockholders are being asked to vote on matters that are deemed "non-routine" and for which brokers do not have discretionary voting power.
THE BOARD RECOMMENDS THAT OUR STOCKHOLDERS VOTE "FOR"
PROPOSAL NO. 2 TO ADJOURN THE SPECIAL MEETING, IF NECESSARY, TO SOLICIT
ADDITIONAL PROXIES.
10
PRINCIPAL STOCKHOLDERS
The following table sets forth information, to the extent known by us or ascertainable from public filings, with respect to the beneficial ownership of our Common Stock as of
• each of our directors;
• each of our Named Executive Officers;
• all of our directors and executive officers as a group; and
• each person, or group of affiliated persons, who is known by us to beneficially owner of greater-than-5.0% of our voting securities.
We have determined beneficial ownership in accordance with the rules of the
We have based our calculation of the percentage of beneficial ownership prior to this offering on 24,966,053 shares of Common Stock outstanding as of
|
|
Amount and |
Percent of |
|||
|
|
2,494,109 |
9.99 |
% |
||
|
|
2,494,109 |
9.99 |
% |
||
|
|
2,632,517 |
9.99 |
% |
||
|
|
1,847,565 |
7.38 |
% |
||
|
|
1,590,738 |
6.37 |
% |
||
|
|
1,590,738 |
6.37 |
% |
||
|
Directors and Named Executive Officers |
|||||
|
|
184,054 |
* |
|||
|
|
17,087 |
* |
|||
|
Dr. |
67,043 |
* |
|||
|
|
- |
- |
|||
|
Dr. |
14,071 |
* |
|||
|
Dr. |
- |
- |
|||
|
|
- |
- |
|||
|
|
- |
- |
|||
|
Dr. |
7,582 |
* |
|||
|
|
1,537 |
* |
|||
|
All directors and executive officers as a group (10 persons) |
291,374 |
1.17 |
% |
||
____________
* Less than 1%.
(1) Unless otherwise indicated, the business address of each of the individuals is c/o
(2) Based on certain information made available to the Company and on the Schedule 13G/A filed with the
Represents 2,494,109 shares of Common Stock and excludes (i) 1,308,800 shares of Common Stock issuable upon conversion of 13,088 shares of Series X Preferred Stock (subject to a 9.99% beneficial ownership limitation), (ii) 1,081,750 shares of Common Stock issuable upon exercise of the Private Placement Common Warrants (subject to a 9.99% beneficial ownership limitation), (iii) 1,174,859 shares of Common Stock issuable upon exercise of New Warrants (subject to a 9.99% beneficial ownership blocker). (iv) 375,399 shares of Common Stock issuable upon exercise of certain amended and restated
11
warrants (subject to a beneficial ownership blocker) issued on
The address of
(3) Based on certain information made available to the Company and on the Schedule 13G filed jointly with the
As the managing members of Nantahala, each of Messrs. Harkey and Mack may be deemed to be a beneficial owner of the securities reported herein held by Nantahala. Nantahala,
(4) Based on certain information made available to the Company and on the Schedule 13D/A filed jointly with the
Excludes an aggregate of 5,146,706 shares of Common Stock issuable upon conversion of Series X Preferred Stock (subject to a 9.99% beneficial ownership limitation), and Common Stock issuable upon exercise of certain warrants. Some of such warrants will only be exercisable following stockholder approval or are subject to a 9.99% beneficial ownership limitation.
(5) Based on certain information made available to the Company and on the Schedule 13G/A filed jointly with the
OrbiMed BioFund is the general partner of OIP and OrbiMed Israel is the general partner of OrbiMed BioFund. OrbiMed Israel exercises investment power over the securities held by OrbiMed BioFund through an investment committee comprised of
12
(6) Based on certain information made available to the Company. Represents 1,590,738 shares of Common Stock held by
(7) Based on certain information made available to the Company. Represents 1,590,738 shares of Common Stock held by
(8) Represents (i) 53,056 shares of Common Stock, (ii) 1,875 shares of Common Stock issuable upon exercise of certain warrants and (iii) certain options to purchase 129,123 shares of Common Stock that were vested as of the Record Date or will vest within 60 days thereafter.
(9) Represents (i) 375 shares of Common Stock, (ii) 281 shares of Common Stock issuable upon exercise of certain warrants and (iii) certain options to purchase 16,431 shares of Common Stock that were vested as of the Record Date or will vest within 60 days thereafter.
(10) Represents (i) 31,749 shares of Common Stock and (ii) certain options to purchase 35,294 shares of Common Stock that were vested as of the Record Date or will vest within 60 days thereafter.
(11) Represents (i) 375 shares of Common Stock, (ii) 281 shares of Common Stock issuable upon exercise of certain warrants and (iii) certain options to purchase 13,415 shares of Common Stock that were vested as of the Record Date or will vest within 60 days thereafter.
(12) Represents (i) 500 shares of Common Stock, (ii) 375 shares of Common Stock issuable upon exercise of certain warrants and (iii) certain options to purchase 6,707 shares of Common Stock that were vested as of the Record Date or will vest within 60 days thereafter.
(13) Represents certain options to purchase 1,537 shares of Common Stock that were vested as of the Record Date or will vest within 60 days thereafter.
13
WHERE YOU CAN FIND ADDITIONAL INFORMATION
You should rely only on the information contained in this proxy statement or on information to which
If you have more questions about this proxy statement or how to submit your proxy, or if you need additional copies of this proxy statement or the enclosed proxy card or voting instructions, please contact
HOUSEHOLDING OF PROXY MATERIALS
The
This year, several brokers with account holders who are our stockholders will be "householding" our proxy materials. A single set of the proxy materials will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker that they will be "householding" communications to your address, "householding" will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in "householding" and would prefer to receive a separate set of proxy materials, please notify your broker or the Company. Direct your written request to:
Stockholders who currently receive multiple copies of the proxy materials at their addresses and would like to request "householding" of their communications should contact their brokers.
14
STOCKHOLDER PROPOSALS
Pursuant to Rule 14a-8 under the Exchange Act ("Rule 14a-8"), a stockholder who intends to present a proposal at our 2025 annual meeting of stockholders and who wishes the proposal to be included in the proxy statement for the 2025 annual meeting must submit the proposal to us in writing to the attention of our Secretary at
Stockholders wishing to submit proposals to be presented directly at the 2025 annual meeting of stockholders instead of by inclusion in our proxy statement for the 2025 annual meeting must follow the submission criteria set forth in our Bylaws and applicable law concerning stockholder proposals. To be properly brought before the 2025 annual meeting, business either (i) must be specified in a written notice of the 2025 annual meeting (or any supplement thereto) given by or at the direction of the Board or the Chief Executive Officer or Secretary of
For next year's annual meeting, we will be required pursuant to Rule 14a-19 under the Exchange Act to include on our proxy card all nominees for director for whom we have received notice under the rule, which must be received no later than 60 calendar days prior to the anniversary of the Special Meeting. For any such director nominee to be included on our proxy card for next year's annual meeting, notice must be received no later than
OTHER MATTERS
Our Board does not know of any other matters to be brought before the Special Meeting. If any other matters not mentioned in this proxy statement are properly brought before the Special Meeting, the individuals named in the enclosed proxy intend to use their discretionary voting authority under the proxy to vote the proxy in accordance with their best judgment on those matters.
15
SCAN TO VIEW MATERIALS & VOTE BIOMX INC. 22 EINSTEIN ST., FLOOR 4 NESS ZIONA 7414003,
Important Notice Regarding the Availability of Proxy Materials for the Special Meeting:The Notice and Proxy Statement are available at www.proxyvote.com.
Attachments
Disclaimer
Proxy Statement (Form DEF 14A)
Proxy Statement (Form DEF 14A)
Advisor News
- Global economic growth will moderate as the labor force shrinks
- Estate planning during the great wealth transfer
- Main Street families need trusted financial guidance to navigate the new Trump Accounts
- Are the holidays a good time to have a long-term care conversation?
- Gen X unsure whether they can catch up with retirement saving
More Advisor NewsAnnuity News
- Product understanding will drive the future of insurance
- Prudential launches FlexGuard 2.0 RILA
- Lincoln Financial Introduces First Capital Group ETF Strategy for Fixed Indexed Annuities
- Iowa defends Athene pension risk transfer deal in Lockheed Martin lawsuit
- Pension buy-in sales up, PRT sales down in mixed Q3, LIMRA reports
More Annuity NewsHealth/Employee Benefits News
Life Insurance News
- Product understanding will drive the future of insurance
- Nearly Half of Americans More Stressed Heading into 2026, Allianz Life Study Finds
- New York Life Investments Expands Active ETF Lineup With Launch of NYLI MacKay Muni Allocation ETF (MMMA)
- LTC riders: More education is needed, NAIFA president says
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on Malaysia’s Non-Life Insurance Segment
More Life Insurance News